Clinical Trial Update: Evaluation of Vaccinal and Natural Immunity Against Meningococcus C [NA]

View source ↗

Summary

A completed clinical trial evaluated immune responses from vaccination and natural infection against meningococcal serogroup C infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Vaccine study for meningococcal serogroup C (NCT02844088)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Prevention of Meningococcus C Infections | NA | Status: COMPLETED